AcelRx Pharmaceuticals, Inc. (ACRX) was a big mover last session, as its shares rose nearly 12% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the company since Jul 3, as the stock is now down over 12%.
In the last 30 days, the company has not seen any estimate revision and the Zacks Consensus Estimate moved slightly higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
AcelRx Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Better-ranked stocks in the med-drugs industry include Enanta Pharmaceuticals, Inc. (ENTA), Endo International plc (ENDP) and Ironwood Pharmaceuticals, Inc. (IRWD). All three carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ACELRX PHARMACEUTICALS INC (ACRX): Free Stock Analysis Report
ENANTA PHARMACEUTICALS INC (ENTA): Free Stock Analysis Report
ENDO INTERNATIONAL PLC ORD (ENDP): Free Stock Analysis Report
IRONWOOD PHARMACEUTICALS CL A (IRWD): Free Stock Analysis Report
Zacks Investment Research
- Health Care Industry
- Personal Investing Ideas & Strategies